期刊文献+

儿童急性巨核细胞白血病 被引量:6

Childhood Acute Megakaryoblastic Leukemia
下载PDF
导出
摘要 本研究通过实例分析儿童急性巨核细胞白血病(AMKL)的临床、病理和生物学特征。用骨髓细胞涂片观察细胞的形态;用流式细胞技术和免疫组织化学方法检测肿瘤细胞的免疫表型。结果表明:本例以发热、出血、肝脾淋巴结肿大为主要临床症状,白细胞增多伴两系血细胞减少,骨髓干抽,骨髓原始巨核细胞异常增生超过30%,原始细胞的免疫分型为CD41+CD61+。骨髓活检显示,髓内增生的单个核大细胞为CD42b+。最后诊断为急性巨核细胞白血病。结论儿童急性巨核细胞白血病较为少见,容易误诊,预后不好;免疫分型和免疫组织化学检测有助于该病的早期诊断和预后评估。 The aim of this study was to investigate the clinical, pathological and biological features of acute megakaryoblastic leukemia in childhood. The morphology of cells was observed by means of bone marrow smear; the immunophenotype was detected by flow cytometry and immunohistochemistry assay. The results indicated that the fever, hemorrhage, hepatosplenomegaly and lymphadenopathy in this case were the primary presentations accompanying by leukocytosis, anemia and thrombocytopenia. An adequate marrow aspirate could not be obtained. At the time of diagnosis, the bone marrow had more than 30% megakaryoblasts in nucleated cells. Flow cytometric analysis revealed the dual expression of CD41 and CD61 by tumor cells in bone marrow. The histopathological examination of bone marrow demonstrated infiltration of large-sized CD42b^+ cells. According to all above mentioned results, this case was diagnosed as acute megakaryoblastic leukemia. In conclusion, childhood acute megakaryoblastic leukemia is a rare and easily misdiagnosed disease with poor prognosis. Flow cytometry analysis and immunohistochemistry assay of bone marrow can help in detecting this leukemia subtype and evaluating its prognosis.
出处 《中国实验血液学杂志》 CAS CSCD 2007年第3期528-532,共5页 Journal of Experimental Hematology
关键词 白血病 急性巨核细胞白血病 儿童 leukemia acute megakaryoblastic leukemia childhood
  • 相关文献

参考文献17

  • 1Lewis SM,Szur L.Malignant myelosclerosis.Br Med J,1963;2:472-477
  • 2Hassan HT,Freund M.Characteristic biological features of human megakaryoblastic leukemia cell lines.Leuk Res,1995;19:589-594
  • 3Barnard DR,Alonzo TA,Gerbing RB,et al.Comparison of childhood myelodysplastic syndrome,AML FAB M6 or M7,CCG 2891:Report from the Children's Oncology Group.Pediatr Blood Cancer,2006;[Epub ahead of print]
  • 4Carroll A,Civin C,Schneider N,et al.The t(1;22)(p13;q13)is nonrandom and restricted to infants with acute megakaryoblastic leukemia:a Pediatric Oncology Group Study.Blood,1991;78:748-752
  • 5Lion T,Haas OA,Harbott J,et al.The translocation t(1;22)(p13;q13)is a noorandom marker specifically associated with acute megakaryocytic leukemia in young children.Blood,1992;79:3325-3330
  • 6Creutzig U,Harbott J,Sperling C,et al.Clinical significance of surfaceantigen expressionin children with acute myeloid leukemia:results of study AML-BFM-87.Blood,1995;86:3097-3108
  • 7Paredes-Aguilera R,Romero-Guzman L,Lopez-Santiago N,et al.Biology,clinical,and hematologic features of acute megakaryoblastic leukemia in children.Am J Hematol,2003;73:71-80
  • 8Pagano L,Pulsoni A,Vignetti M,et al.Acute megakaryoblastic leukemia:experience of GIMEMA trials.Leukemia,2002;16:1622-1626
  • 9汪亚伦,王彤,许凤,冮岩,王杰.伴有6;9染色体易位急性髓系白血病患者DEK-CAN融合基因表达分析[J].中国实验血液学杂志,2006,14(2):232-236. 被引量:8
  • 10李志刚,吴敏媛,朱平,胡亚美.白血病29种染色体畸变形成的融合基因分析[J].中华儿科杂志,2001,39(11):682-685. 被引量:32

二级参考文献16

  • 1龚辉,刘文励,周剑峰,徐慧珍.急性白血病患者骨髓细胞CHFR基因表达及其临床意义[J].中华医学杂志,2005,85(16):1085-1088. 被引量:2
  • 2Campana D,Blood,1995年,85卷,1416页
  • 3Shapira MY,Hirshberg B,Amir G,et al.6 ;9 translocation in myelodysplastic syndrome.Cancer Genet Cytogenet,1999; 112:57 -59.
  • 4Boer J,Mahmoud H,Raimondi S,et al.Loss of the DEK-CAN fusion transcript in a child with t(6;9) acute myeloid leukemia following chemotherapy and allogeneic bone marrow transplantation.Leukemia,1997; 11:299 -300.
  • 5Potter MN,Cross NC,van-Dongen JJ,et al.Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma:an updated meeting report and review.Leukemia,1993;7:1302-1314.
  • 6Yokota H,Kitamura K.The genetic diagnosis of hematopoietic malignancy by polymerase chain reaction method.Rinsho Byori,2000; 48:708 -715.
  • 7Garcon L,Libura M,Delabesse E,et al.DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.Leukemia,2005; 19:1338-1344.
  • 8Makita M,Azuma T,Hamaguchi H,et al.Leukemia-associated fusion proteins,dek-can and bcr-abl,represent immunogenic HLADR-restricted epitopes recognized by fusion peptide-specific CD4 +T lymphocytes.Leukemia,2002; 16:2400-2407.
  • 9von-Lindem M,van-Baal S,Wiegant J,et al.Can,a putative oncogene associated with myeloid leukemogenesis,may be activated by fusion of its 3' half to different genes:characterization of the set gene.Mol Cell Biol,1992; 12:3346-3355.
  • 10Shearer BM,Knudson RA,Flynn HC,et al.Development of a DFISH method to detect DEK/CAN fusion resulting from t (6;9)(p23 ;q34) in patients with acute myelogenous leukemia.Leukemia,2005; 19:126-131.

共引文献38

同被引文献44

  • 1薛素冰.分化型巨核细胞白血病误诊红血病1例[J].张家口医学院学报,2004,21(3):73-73. 被引量:1
  • 2金彦,张文艺,李泳浩.小儿急性巨核细胞白血病误诊1例[J].中国误诊学杂志,2004,4(5):683-683. 被引量:2
  • 3陈新敏,冯文莉.慢性粒细胞白血病急变的机理[J].国外医学(输血及血液学分册),2005,28(1):21-23. 被引量:4
  • 4刘曼玲,荆亚茹,周小兰,李占魁.新生儿白血病的诊疗现状[J].国外医学(儿科学分册),2005,32(5):316-318. 被引量:5
  • 5陈琴,刘勇.小儿急性巨核细胞白血病1例[J].罕少疾病杂志,2005,12(5):57-58. 被引量:1
  • 6Athale UH,Razzouk BI,Raimond SC,et al.Biology and outcome of childhood actute megakaryoblastic leukemia:A Single institution's experience.Blood,2001,97:3727-3732.
  • 7Tallman M,Neuberg D,Bennett JM,et al.Acute megakaryoblastic leukemia:the eastern cooperative incology group experience.Blood,2000,96:2405-2411.
  • 8Draker BJ,Guilhot F,O'Brien SG,et al.Five-year followup of patients receiving imatinib for chronic myeloid leukemia.New Engnland Journal of Medicine,2006,335:2408-2417.
  • 9Campiontti L,Grandi AM,Biotti MG,et al.Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia.American Journal of Heamatology,2007,82:231-233.
  • 10Kantarjian HM,Cortes J,O'Brien S,et al.Imatinib mesylate(STL571)therapy for chromosome-positive chronic myelogenous leukemia in biast phase.Blood,2002,99:3547-3553.

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部